Purple Biotech

T cells attack cancer cell
#AACR 2023 #Cancer research #Melanoma #Oncology #Purple Biotech #Tumour microenvironment (TME)

New drug could help overcome tumour resistance to treatment

New study results have demonstrated the potential of a new drug to reprogramme the immune profile in the tumour microenvironment (TME) and convert resistant tumours to responders to Immune Checkpoint Blockage (ICB) therapies. Purple Biotech shared the new results at the American Association for Cancer Research… Read More

#Cancer Research #News